Filing Flows

Filing Flows › Zimmer Biomet Holdings (ZBH) › Q3 2025

Zimmer Biomet Holdings (ZBH) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 5, 2025

Zimmer Biomet Holdings (ZBH) reported revenue of $2.0B for the third quarter 2025 (Q3 2025), +10% from a year earlier and -4% from the quarter before. Operating margin was 17.6%, net earnings $231M (11.6% of revenue).

Revenue$2.0B
Year over year+10%
Quarter over quarter-4%
Operating margin17.6%
Net earnings$231M

Zimmer Biomet Holdings, Q3 2025: revenue $2.0B (+10% year over year), operating margin 17.6%, net earnings $231M, operating cash flow $419M. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$2.0B-4%+10%
Operating profit$351M+17%+26%
Net earnings$231M+51%-7%
Operating cash flow$419M+11%+6%
Free cash flow$278M——

What changed

Revenue was $2.0B in Q3 2025, up 10% year over year and down 4% from the previous quarter. Knees was the largest line at 40% of revenue. SET added $0.09B year over year (up 19%), 49% of the total change.

Operating profit was $0.35B, a 17.6% margin (up 2.2 points year over year). Of the extra revenue versus a year earlier, 41% reached operating profit, above the 15% margin then. Total costs grew 7% against revenue growth of 10%. The fastest-growing cost line was SG&A (+14%). Net earnings were $0.23B, down 7% year over year. The effective tax rate was 17.2%.

Operating cash flow was $0.42B (up 6% year over year), 181% of net earnings. Non-cash charges added back $0.28B of depreciation and amortization and $0.03B of share-based compensation. Working capital and other items used $0.12B. After itions to instruments ($0.09B) and itions to other property, plant and equipment ($0.06B), free cash flow as the company reports it was $0.28B.

Questions

What was Zimmer Biomet Holdings' revenue in the third quarter 2025?

Zimmer Biomet Holdings (ZBH) reported revenue of $2.0B for the third quarter 2025 (Q3 2025), +10% from a year earlier and -4% from the quarter before.

Was Zimmer Biomet Holdings profitable in the third quarter 2025?

Operating profit was $351M (17.6% of revenue) and net earnings $231M.

Open the interactive Sankey →

Source: Zimmer Biomet Holdings 10-Q on SEC EDGAR.